Global X Data Center & Digital Infra ETF vs GSK plc — how do they compare? Global X Data Center & Digital Infra ETF trades at $27.65 (market cap $2.04B), while GSK plc trades at $46.52 (market cap $91.88B). The key difference: GSK plc is far larger — about 45× Global X Data Center & Digital Infra ETF's market cap, and GSK plc pays a 3.9% dividend while Global X Data Center & Digital Infra ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Global X Data Center & Digital Infra ETF for 15 Days and GSK plc for 93 Days on average.
| DTCR | GSK | |
|---|---|---|
Market Cap | $2.04B | $91.88B |
Volume | 899,532 | 7,730,529 |
Sector | Sector/Thematic | Health |
52-Week High | $32.46 | $61.18 |
52-Week Low | $19.73 | $43.24 |
Typical Hold Time | 15 Days | 93 Days |
Enterprise Value | — | $111.88B |
Dividend Yield | — | 3.9% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
GSK trades at $46.45, down 1.21% with bearish technical signals. The company shows strong fundamentals with revenue growth to $32.67B in 2025 and consistent earnings beats. Valuation metrics appear reasonable with P/E of 14.89 and EV/EBITDA of 8.75. Recent developments include strategic oncology partnerships and a $750M cancer therapy acquisition, positioning for long-term growth despite near-term technical weakness.
GSK presents a mixed outlook with strong profitability and pipeline expansion offset by technical bearishness and HIV patent concerns. The company's 29.73% ROE and recent earnings outperformance support investment appeal, while the bearish moving average signal and competitive pressures warrant caution. Analyst consensus leans hold with 55% neutral rating, suggesting balanced risk-reward for long-term investors.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Global X Data Center & Digital Infrastructure ETF seeks exposure to companies involved in data centers and digital infrastructure. Its holdings span areas such as digital infrastructure, networking, and related real estate.
Read more on DTCR →In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →